Kalion
2011
FOUNDED
PRIVATE
STATUS
Series A3
LATEST DEAL TYPE
$3M
LATEST DEAL AMOUNT
7
INVESTORS
Description
Producer of glucaric acid and glucuronic acid designed to transform the traditional chemical industry by providing renewable access to the molecule. The company's acid are prepared using traditional, green, fermentation technology through advanced fermentation methods, utilizing patented microbes which are created using proprietary synthetic biology techniques, enabling industrial chemical industry to eliminate the use of oil-based materials and substantially below the traditional chemical based route.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Industrial Chemicals
Other Industries
Other Chemicals and Gases
Primary Office
- 92 Elm Street
- Milton, MA 02186
- United States
+1 (240) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Kalion’s full profile, request a free trial.
Kalion Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC (Series A3) | 11-Mar-2019 | $3M | 00.000 | 000.00 | Completed | Generating Revenue |
| 6. Grant | 01-Jan-2018 | 00000 | 00.000 | Completed | Generating Revenue | |
| 5. Later Stage VC (Series A2) | 03-Mar-2017 | 00000 | 00.000 | 00.000 | Completed | Generating Revenue |
| 4. Early Stage VC (Series A1) | 30-Apr-2015 | 00000 | 00.000 | 00.000 | Completed | Generating Revenue |
| 3. Grant | 01-Jan-2015 | 00000 | 00.000 | Completed | Generating Revenue | |
| 2. Early Stage VC (Series A) | 01-Nov-2013 | $747K | $1.75M | 00.000 | Completed | Generating Revenue |
| 1. Angel (individual) | 01-Feb-2013 | $1M | $1M | 00.00 | Completed | Generating Revenue |
Kalion Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series A3 | 0,000,000 | 00.000000 | 00.00 | 00.0 | 00.0 | 00 | 00.0 | 000 |
| Series A2 | 0,000,000 | 00.000000 | 00.00 | 00.0 | 00.0 | 00 | 00.0 | 00.000 |
| Series A1 | 2,223,343 | $0.001000 | $0.03 | $0.4 | $0.4 | 1x | $0.4 | 10.67% |
| Series A | 3,225,186 | $0.001000 | $0.02 | $0.31 | $0.31 | 1x | $0.31 | 15.48% |
Kalion Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Jean Hammond | Angel (individual) | Minority | 000 0000 | 000000 0 | ||
| Launchpad Venture Group | Angel Group | Minority | 000 0000 | 000000 0 | ||
| National Science Foundation | Government | 000 0000 | 000000 0 | |||
| Alicia Syrett | Angel (individual) | Minority | 000 0000 | 000000 0 | ||
| Beta Fund | Venture Capital | Minority | 000 0000 | 000000 0 |
Kalion Executive Team (4)
1 Former Executive
You’re viewing 3 of 4 executives. Get the full list »Kalion Board Members (6)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Darcy Prather | Kalion | Chief Executive Officer, President & Board Member | 000 0000 | |
| Joan Zief | Golden Seeds | Board Member | 000 0000 | |
| Kristala Prather Ph.D | Kalion | Co-Founder, Chief Scientist & Board Member | 000 0000 | |
| Melissa Kent | Self | Board Member | 000 0000 | |
| Nada Jain Ph.D | Golden Seeds | Board Member | 000 0000 |